valproic acid has been researched along with diphenylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Baek, S; Choi, H; Heo, YT; Kim, J; Kim, NH; Quan, X; Xu, YN | 1 |
| Chen, Y; Cui, G; Li, M; Meng, F; Yu, Z; Zhang, Y | 1 |
1 review(s) available for valproic acid and diphenylamine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for valproic acid and diphenylamine
| Article | Year |
|---|---|
CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells.
Topics: Animals; Animals, Genetically Modified; Benzamides; Blastocyst; Cattle; Cells, Cultured; CRISPR-Cas Systems; Diphenylamine; Fertilization in Vitro; Fibroblasts; Gene Knock-In Techniques; Genetic Engineering; Genetic Enhancement; Genetic Loci; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Homologous Recombination; Induced Pluripotent Stem Cells; Mice; Mice, SCID; Polymorphism, Restriction Fragment Length; Pyridines; Pyrimidines; Recombinant Fusion Proteins; Teratoma; Transcription Factors; Valproic Acid | 2015 |
Combination of SB431542, CHIR99021 and PD0325901 has a synergic effect on abrogating valproic acid‑induced epithelial‑mesenchymal transition and stemness in HeLa, 5637 and SCC‑15 cells.
Topics: Benzamides; Dioxoles; Diphenylamine; Drug Synergism; Epithelial-Mesenchymal Transition; HeLa Cells; Humans; Neoplasms; Neoplastic Stem Cells; Pyridines; Pyrimidines; Valproic Acid | 2019 |